Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trialPablo Ryan, Estebán Martínez, Peré Domingo et al.|The Lancet HIV|2025Cited by 22
Profile of suicides in a spanish cohort of people living with HIV (PLWH)Julián Olalla, Francisco Rivas‐Ruiz, Joaquim Peraire et al.|Journal of Affective Disorders Reports|2025Cited by 0
Corrigendum to ‘Profile of suicides in a spanish cohort of people living with HIV (PLWH)’ [Journal of Affective Disorders Reports 22 (2025)100980]Julián Olalla, Joaquim Peraire, Rochelly de Azevedo Fernandez et al.|Journal of Affective Disorders Reports|2025Cited by 0